一二三四区视频,亚洲少妇熟女色,日本久热无码视频网,欧美国产日韩大尺度,亚洲a视频,久久少妇一区二区,日韩999无码视频,刺激久久久久久久,啊啊啊啊不要啊在线

Welcome to chemicalbook!
+1 (818) 612-2111
RFQ
Try our best to find the right business for you.
Do not miss inquiry messages Please log in to view all inquiry messages.

Welcome back!

RFQ
skype
MY Account
Top
Postion:Product Catalog >Biochemical Engineering>Biochemical Reagents>Agonist Inhibitors>Altiratinib
Altiratinib
  • Altiratinib

Altiratinib NEW

Price $48 $79 $139
Package 5mg 10mg 25mg
Supply Ability: 10g
Update Time: 2026-04-20

Product Details

Product Name: Altiratinib CAS No.: 1345847-93-9
Purity: 99.75% Supply Ability: 10g
Release date: 2026/04/20

Product Introduction

Bioactivity

NameAltiratinib
DescriptionAltiratinib (DCC-2701)(DCC-2701) is a novel c-MET/TIE-2/VEGFR inhibitor; effectively reduce tumor burden in vivo and block c-MET pTyr(1349)-mediated signaling, cell growth and migration as compared with an HGF antagonist in vitro.
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature.
Solubility Information10% DMSO+40% PEG300+5% Tween 80+45% Saline : 2 mg/mL (3.92 mM), Sonication is recommended.
DMSO : 240 mg/mL (470.16 mM), Sonication is recommended.
KeywordsVEGFR | Vascular endothelial growth factor receptor | Tropomyosin related kinase receptor | Trkreceptor | TrkC | TrkA | Trk receptor | Tie-2 | Tie2 | Inhibitor | inhibit | HGFR | Fms like tyrosine kinase 3 | FLT3 | DCC2701 | DCC 2701 | c-Met/HGFR | cMet/HGFR | c-Met | cMet | Cluster of differentiation antigen 135 | CD135 | Altiratinib
Inhibitors RelatedRibociclib | Gilteritinib | Decanoic Acid | Sorafenib | Pexidartinib | Nintedanib esylate | Afatinib | Chloramphenicol | Bacitracin Zinc | Lenvatinib | NSI-189 Phosphate | Pazopanib
Related Compound LibrariesReprogramming Compound Library | Anti-Pancreatic Cancer Compound Library | Bioactive Compound Library | Membrane Protein-targeted Compound Library | Tyrosine Kinase Inhibitor Library | Kinase Inhibitor Library | Anti-Cancer Clinical Compound Library | Drug Repurposing Compound Library | Inhibitor Library | Bioactive Compounds Library Max | Anti-Cancer Drug Library | Anti-Cancer Active Compound Library

Company Profile Introduction

Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers. TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.

You may like

Recommended supplier

Product name Price   Suppliers Update time
$1.00
VIP8Y
Career Henan Chemical Co
2019-09-06

TargetMol Chemicals Inc.

6YR United StatesUnited States
  • Since: 2011-01-07
  • Address: 36 Washington Street, Wellesley Hill, MA
INQUIRY
临潭县| 司法| 文山县| 旌德县| 昌图县| 富顺县| 莫力| 比如县| 沙坪坝区| 普兰县| 呼玛县| 南充市| 张家川| 英德市| 当阳市| 东乡| 怀仁县| 邯郸县| 达拉特旗| 赣榆县| 上杭县| 咸宁市| 长葛市| 苍南县| 宜丰县| 临漳县| 广元市| 博爱县| 东乌| 霍林郭勒市| 文成县| 乌苏市| 东莞市| 漳浦县| 苗栗市| 深圳市| 仙桃市| 德江县| 甘孜| 弥勒县| 阿勒泰市|